Details for New Drug Application (NDA): 218538
✉ Email this page to a colleague
NDA 218538 describes CHROMIC CHLORIDE, which is a drug marketed by Abraxis Pharm, Rk Pharma, and Hospira, and is included in three NDAs. It is available from one supplier. Additional details are available on the CHROMIC CHLORIDE profile page.
The generic ingredient in CHROMIC CHLORIDE is chromic chloride. Two suppliers are listed for this compound. Additional details are available on the chromic chloride profile page.
The generic ingredient in CHROMIC CHLORIDE is chromic chloride. Two suppliers are listed for this compound. Additional details are available on the chromic chloride profile page.
Summary for 218538
| Tradename: | CHROMIC CHLORIDE |
| Applicant: | Rk Pharma |
| Ingredient: | chromic chloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218538
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CHROMIC CHLORIDE | chromic chloride | INJECTABLE;INJECTION | 218538 | ANDA | Archis Pharma LLC | 72819-235 | 72819-235-16 | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (72819-235-16) / 10 mL in 1 VIAL, SINGLE-DOSE (72819-235-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.004MG CHROMIUM/ML | ||||
| Approval Date: | Nov 18, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
